These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Impact of continuous and pulsatile insulin delivery on net hepatic glucose uptake. Grubert JM; Lautz M; Lacy DB; Moore MC; Farmer B; Penaloza A; Cherrington AD; McGuinness OP Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E232-40. PubMed ID: 15755768 [TBL] [Abstract][Full Text] [Related]
10. Chronic hepatic artery ligation does not prevent liver from differentiating portal vs. peripheral glucose delivery. Moore MC; Burish MJ; Farmer B; Neal DW; Pan C; Cherrington AD Am J Physiol Endocrinol Metab; 2003 Oct; 285(4):E845-53. PubMed ID: 12773306 [TBL] [Abstract][Full Text] [Related]
11. Impact of chronic fructose infusion on hepatic metabolism during TPN administration. Donmoyer CM; Lacy DB; Zhang Y; Chen SS; McGuinness OP Am J Physiol Endocrinol Metab; 2002 Dec; 283(6):E1151-8. PubMed ID: 12424103 [TBL] [Abstract][Full Text] [Related]
12. Role of the hepatic sympathetic nerves in the regulation of net hepatic glucose uptake and the mediation of the portal glucose signal. Dicostanzo CA; Dardevet DP; Neal DW; Lautz M; Allen E; Snead W; Cherrington AD Am J Physiol Endocrinol Metab; 2006 Jan; 290(1):E9-E16. PubMed ID: 16105863 [TBL] [Abstract][Full Text] [Related]
13. Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization. Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E380-4. PubMed ID: 18056788 [TBL] [Abstract][Full Text] [Related]
14. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas. Sekigami T; Shimoda S; Nishida K; Matsuo Y; Ichimori S; Ichinose K; Shichiri M; Sakakida M; Araki E J Artif Organs; 2004; 7(2):91-100. PubMed ID: 15309676 [TBL] [Abstract][Full Text] [Related]
15. Comparison of blood glucose concentrations after administration of a glucose solution via the jugular vein and portal vein in cows. Braun U; Heusmann B; Camenzind D; Haessig M J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):398-400. PubMed ID: 17877578 [TBL] [Abstract][Full Text] [Related]
16. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance. Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727 [TBL] [Abstract][Full Text] [Related]
17. Effect of hepatic portal glucose concentration on food intake and metabolism. Tordoff MG; Tluczek JP; Friedman MI Am J Physiol; 1989 Dec; 257(6 Pt 2):R1474-80. PubMed ID: 2690650 [TBL] [Abstract][Full Text] [Related]
18. Enteral infusion of glucose at rates approximating EGP enhances glucose disposal but does not cause hypoglycemia. Zangeneh F; Basu R; Shah P; Arora P; Camilleri M; Rizza RA Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E280-6. PubMed ID: 12857674 [TBL] [Abstract][Full Text] [Related]
19. Effects of the nitric oxide donor SIN-1 on net hepatic glucose uptake in the conscious dog. An Z; DiCostanzo CA; Moore MC; Edgerton DS; Dardevet DP; Neal DW; Cherrington AD Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E300-6. PubMed ID: 18029444 [TBL] [Abstract][Full Text] [Related]
20. Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II. Fueger PT; Lee-Young RS; Shearer J; Bracy DP; Heikkinen S; Laakso M; Rottman JN; Wasserman DH Diabetes; 2007 Oct; 56(10):2476-84. PubMed ID: 17639019 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]